Linobo, Rosita D.
HRN: 27-22-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/06/2025
06/13/2025
IV
500mg
OD
R/i VAP In Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose LEVOFLOXACIN 750MG IV QD (NAG)
Final appropriateness: Yes
Overall appropriateness: Yes